Tirzepatide 10mg

The dual-pathway metabolic compound. GLP-1 and GIP receptors — activated simultaneously.

$ 195.00

Personalized guidance 1 on 1

Full refund if our licensed clinician determines the treatment isn’t a fit for you

MOA

Overview

Tirzepatide is the first dual GIP and GLP-1 receptor agonist — a molecule that activates two distinct incretin hormone pathways at once for a synergistic metabolic effect that neither pathway achieves alone. It is the active ingredient in FDA-approved Mounjaro and Zepbound. This 10mg research vial represents the maintenance and upper-range dose used in established protocols.

What it does

Tirzepatide works across five simultaneous pathways: central appetite suppression via hypothalamic GLP-1 and GIP receptor activation, increased fat oxidation and thermogenesis through GIP receptor activity in adipose tissue, delayed gastric emptying that extends satiety and blunts post-meal glucose spikes, glucose-dependent insulin stimulation that avoids hypoglycaemia risk, and altered lipid partitioning in adipocytes that shifts the fat stored-to-fat-burned ratio.

Research areas

Obesity and metabolic syndrome · Type 2 diabetes management · Body composition and visceral fat reduction · Cardiovascular risk reduction · Glucose and insulin regulation research

Key facts

Form	Lyophilised powder — requires reconstitution with bacteriostatic water
Storage	Lyophilised: -20°C. Reconstituted: 2–8°C, use within 28 days
Purity	≥99% — third-party COA verified, batch-specific documentation included

For research use only. Not for human consumption. This product is not approved for human use by the FDA or any regulatory body.

More Information

All products offered on this website are intended solely for laboratory research and development purposes. They are not approved for human or veterinary use.

Statements on this site have not been evaluated by the U.S. Food and Drug Administration (FDA). Products are not intended to diagnose, treat, cure, mitigate, or prevent any disease.

Products are manufactured in U.S.-based facilities operating under applicable cGMP standards. This website does not operate as a compounding pharmacy under Section 503A of the Federal Food, Drug, and Cosmetic Act.

A valid health screening is required prior to order fulfillment. After checkout, you will receive instructions to complete the required intake process. Orders will be processed once the screening has been completed and approved. Each completed screening remains valid for 12 months.